RESUMO
Multivalent lectin-glycan interactions (MLGIs) are pivotal for viral infections and immune regulation. Their structural and biophysical data are thus highly valuable, not only for understanding their basic mechanisms but also for designing potent glycoconjugate therapeutics against target MLGIs. However, such information for some important MGLIs remains poorly understood, greatly limiting research progress. We have recently developed densely glycosylated nanoparticles, e.g., â¼4 nm quantum dots (QDs) or â¼5 nm gold nanoparticles (GNPs), as mechanistic probes for MLGIs. Using two important model lectin viral receptors, DC-SIGN and DC-SIGNR, we have shown that these probes can not only offer sensitive fluorescence assays for quantifying MLGI affinities, but also reveal key structural information (e.g., binding site orientation and binding mode) useful for MLGI targeting. However, the small sizes of the previous scaffolds may not be optimal for maximising MLGI affinity and targeting specificity. Herein, using α-manno-α-1,2-biose (DiMan) functionalised GNP (GNP-DiMan) probes, we have systematically studied how GNP scaffold size (e.g., 5, 13, and 27 nm) and glycan density (e.g., 100, 75, 50 and 25%) determine their MLGI affinities, thermodynamics, and antiviral properties. We have developed a new GNP fluorescence quenching assay format to minimise the possible interference of GNP's strong inner filter effect in MLGI affinity quantification, revealing that increasing the GNP size is highly beneficial for enhancing MLGI affinity. We have further determined the MLGI thermodynamics by combining temperature-dependent affinity and Van't Hoff analyses, revealing that GNP-DiMan-DC-SIGN/R binding is enthalpy driven with favourable binding Gibbs free energy changes (ΔG°) being enhanced with increasing GNP size. Finally, we show that increasing the GNP size significantly enhances their antiviral potency. Notably, the DiMan coated 27 nm GNP potently and robustly blocks both DC-SIGN and DC-SIGNR mediated pseudo-Ebola virus cellular entry with an EC50 of â¼23 and â¼49 pM, respectively, making it the most potent glycoconjugate inhibitor against DC-SIGN/R-mediated Ebola cellular infections. Our results have established GNP-glycans as a new tool for quantifying MLGI biophysical parameters and revealed that increasing the GNP scaffold size significantly enhances their MLGI affinities and antiviral potencies.
Assuntos
Antivirais , Ouro , Nanopartículas Metálicas , Polissacarídeos , Termodinâmica , Ouro/química , Nanopartículas Metálicas/química , Humanos , Antivirais/química , Antivirais/farmacologia , Polissacarídeos/química , Lectinas Tipo C/metabolismo , Lectinas Tipo C/química , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/química , Receptores de Superfície Celular/metabolismo , Receptores de Superfície Celular/química , Lectinas/química , Lectinas/metabolismoRESUMO
Aptamers are single-stranded RNA or DNA molecules that can specifically bind to targets and have found broad applications in cancer early-stage detection, accurate drug delivery, and precise treatment. Although various aptamer screening methods have been developed over the past several decades, the accurate binding site between the target and the aptamer cannot be characterized during a typical aptamer screening process. In this research, we chose a widely used aptamer screened by our group, sgc8c, and its target protein tyrosine kinase 7 (PTK7) as the model aptamer and target and tried to determine the binding site between aptamer sgc8c and PTK7. Through sequential protein truncation, we confirmed that the exact binding site of sgc8c was within the region of Ig 3 to Ig 4 in the extracellular domain of PTK7. Using in vitro expressed Ig (3-4), we successfully acquired the crystal of an sgc8c-Ig (3-4) binding complex. The possible sgc8c-binding amino acid residues on PTK7 and PTK7-binding nucleotide residues on sgc8c were further identified and simulated by mass spectrometry and molecular dynamics simulation and finally verified by aptamer/protein truncation and mutation.
Assuntos
Aptâmeros de Nucleotídeos , Moléculas de Adesão Celular , Receptores Proteína Tirosina Quinases , Aptâmeros de Nucleotídeos/química , Aptâmeros de Nucleotídeos/metabolismo , Sítios de Ligação , Humanos , Receptores Proteína Tirosina Quinases/metabolismo , Receptores Proteína Tirosina Quinases/química , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/química , Simulação de Dinâmica MolecularRESUMO
Plasma membrane proteins (PMPs) play critical roles in a myriad of physiological and disease conditions. A unique subset of PMPs functions through interacting with each other in trans at the interface between two contacting cells. These trans-interacting PMPs (tiPMPs) include adhesion molecules and ligands/receptors that facilitate cell-cell contact and direct communication between cells. Among the tiPMPs, a significant number have apparent extracellular binding domains but remain orphans with no known binding partners. Identification of their potential binding partners is therefore important for the understanding of processes such as organismal development and immune cell activation. While a number of methods have been developed for the identification of protein binding partners in general, very few are applicable to tiPMPs, which interact in a two-dimensional fashion with low intrinsic binding affinities. In this review, we present the significance of tiPMP interactions, the challenges of identifying binding partners for tiPMPs, and the landscape of method development. We describe current avidity-based screening approaches for identifying novel tiPMP binding partners and discuss their advantages and limitations. We conclude by highlighting the importance of developing novel methods of identifying new tiPMP interactions for deciphering the complex protein interactome and developing targeted therapeutics for diseases.
Assuntos
Proteínas de Membrana , Ligação Proteica , Humanos , Proteínas de Membrana/metabolismo , Membrana Celular/metabolismo , Comunicação Celular , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/química , Mapeamento de Interação de Proteínas/métodos , Animais , LigantesRESUMO
The Red Queen Hypothesis (RQH), derived from Lewis Carroll's "Through the Looking-Glass", postulates that organisms must continually adapt in response to each other to maintain relative fitness. Within the context of host-pathogen interactions, the RQH implies an evolutionary arms race, wherein viruses evolve to exploit hosts and hosts evolve to resist viral invasion. This study delves into the dynamics of the RQH in the context of virus-cell interactions, specifically focusing on virus receptors and cell receptors. We observed multiple virus-host systems and noted patterns of co-evolution. As viruses evolved receptor-binding proteins to effectively engage with cell receptors, cells countered by altering their receptor genes. This ongoing mutual adaptation cycle has influenced the molecular intricacies of receptor-ligand interactions. Our data supports the RQH as a driving force behind the diversification and specialization of both viral and host cell receptors. Understanding this co-evolutionary dance offers insights into the unpredictability of emerging viral diseases and potential therapeutic interventions. Future research is crucial to dissect the nuanced molecular changes and the broader ecological consequences of this ever-evolving battle. Here, we combine phylogenetic inferences, structural modeling, and molecular dynamics analyses to describe the epidemiological characteristics of major Brazilian DENV strains that circulated from 1990 to 2022 from a combined perspective, thus providing us with a more detailed picture on the dynamics of such interactions over time.
Assuntos
Moléculas de Adesão Celular , Vírus da Dengue , Evolução Molecular , Interações Hospedeiro-Patógeno , Receptores de Superfície Celular , Proteínas do Envelope Viral , Envelope Viral , Humanos , Brasil , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/genética , Moléculas de Adesão Celular/química , Dengue/virologia , Vírus da Dengue/genética , Vírus da Dengue/metabolismo , Interações Hospedeiro-Patógeno/genética , Lectinas Tipo C/metabolismo , Lectinas Tipo C/genética , Lectinas Tipo C/química , Simulação de Dinâmica Molecular , Filogenia , Ligação Proteica , Receptores de Superfície Celular/metabolismo , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/química , Receptores Virais/metabolismo , Receptores Virais/química , Receptores Virais/genética , Envelope Viral/metabolismo , Proteínas do Envelope Viral/genética , Proteínas do Envelope Viral/metabolismo , Proteínas do Envelope Viral/químicaRESUMO
Vasodilator-stimulated phosphoprotein (VASP) family proteins play a crucial role in mediating the actin network architecture in the cytoskeleton. The Ena/VASP homology 2 (EVH2) domain in each of the four identical arms of the tetrameric VASP consists of a loading poly-Pro region, a G-actin-binding domain (GAB), and an F-actin-binding domain (FAB). Together, the poly-Pro, GAB, and FAB domains allow VASP to bind to sides of actin filaments in a bundle, and recruit profilin-G-actin to processively elongate the filaments. The atomic resolution structure of the ternary complex, consisting of the loading poly-Pro region and GAB domain of VASP with profilin-actin, has been solved over a decade ago; however, a detailed structure of the FAB-F-actin complex has not been resolved to date. Experimental insights, based on homology of the FAB domain with the C region of WASP, have been used to hypothesize that the FAB domain binds to the cleft between subdomains 1 and 3 of F-actin. Here, in order to develop our understanding of the VASP-actin complex, we first augment known structural information about the GAB domain binding to actin with the missing FAB domain-actin structure, which we predict using homology modeling and docking simulations. In earlier work, we used mutagenesis and kinetic modeling to study the role of domain-level binding-unbinding kinetics of Ena/VASP on actin filaments in a bundle, specifically on the side of actin filaments. We further look at the nature of the side-binding of the FAB domain of VASP at the atomistic level using our predicted structure, and tabulate effective mutation sites on the FAB domain that would disrupt the VASP-actin complex. We test the binding affinity of Ena with mutated FAB domain using total internal reflection fluorescence microscopy experiments. The binding affinity of VASP is affected significantly for the mutant, providing additional support for our predicted structure.
Assuntos
Actinas , Moléculas de Adesão Celular , Proteínas dos Microfilamentos , Fosfoproteínas , Ligação Proteica , Proteínas dos Microfilamentos/metabolismo , Proteínas dos Microfilamentos/química , Proteínas dos Microfilamentos/genética , Actinas/metabolismo , Fosfoproteínas/metabolismo , Fosfoproteínas/química , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/química , Moléculas de Adesão Celular/genética , Humanos , Sítios de LigaçãoRESUMO
Nectin and nectin-like (Necl) co-receptor axis, comprised of receptors DNAM-1, TIGIT, CD96, PVRIG, and nectin/Necl ligands, is gaining prominence in immuno-oncology. Within this axis, the inhibitory receptor PVRIG recognizes Nectin-2 with high affinity, but the underlying molecular basis remains unknown. By determining the crystal structure of PVRIG in complex with Nectin-2, we identified a unique CC' loop in PVRIG, which complements the double-lock-and-key binding mode and contributes to its high affinity for Nectin-2. The association of the corresponding charged residues in the F-strands explains the ligand selectivity of PVRIG toward Nectin-2 but not for Necl-5. Moreover, comprehensive comparisons of the binding capacities between co-receptors and ligands provide innovative insights into the intra-axis immunoregulatory mechanism. Taken together, these findings broaden our understanding of immune recognition and regulation mediated by nectin/Necl co-receptors and provide a rationale for the development of immunotherapeutic strategies targeting the nectin/Necl axis.
Assuntos
Modelos Moleculares , Nectinas , Ligação Proteica , Receptores de Superfície Celular , Humanos , Sítios de Ligação , Moléculas de Adesão Celular/metabolismo , Moléculas de Adesão Celular/química , Moléculas de Adesão Celular/imunologia , Cristalografia por Raios X , Ligantes , Nectinas/metabolismo , Nectinas/química , Receptores Imunológicos/metabolismo , Receptores Imunológicos/química , Receptores de Superfície Celular/química , Receptores de Superfície Celular/metabolismoRESUMO
C-type lectins are a large superfamily of proteins involved in a multitude of biological processes. In particular, their involvement in immunity and homeostasis has rendered them attractive targets for diverse therapeutic interventions. They share a characteristic C-type lectin-like domain whose adaptability enables them to bind a broad spectrum of ligands beyond the originally defined canonical Ca2+-dependent carbohydrate binding. Together with variable domain architecture and high-level conformational plasticity, this enables C-type lectins to meet diverse functional demands. Secondary sites provide another layer of regulation and are often intricately linked to functional diversity. Located remote from the canonical primary binding site, secondary sites can accommodate ligands with other physicochemical properties and alter protein dynamics, thus enhancing selectivity and enabling fine-tuning of the biological response. In this review, we outline the structural determinants allowing C-type lectins to perform a large variety of tasks and to accommodate the ligands associated with it. Using the six well-characterized Ca2+-dependent and Ca2+-independent C-type lectin receptors DC-SIGN, langerin, MGL, dectin-1, CLEC-2 and NKG2D as examples, we focus on the characteristics of non-canonical interactions and secondary sites and their potential use in drug discovery endeavors.
Assuntos
Lectinas Tipo C , Lectinas Tipo C/química , Lectinas Tipo C/metabolismo , Humanos , Ligantes , Sítios de Ligação , Cálcio/metabolismo , Cálcio/química , Receptores de Superfície Celular/química , Receptores de Superfície Celular/metabolismo , Moléculas de Adesão Celular/química , Moléculas de Adesão Celular/metabolismo , Ligação Proteica , Lectinas de Ligação a Manose/química , Lectinas de Ligação a Manose/metabolismo , Lectina de Ligação a Manose/química , Lectina de Ligação a Manose/metabolismo , Subfamília K de Receptores Semelhantes a Lectina de Células NK/química , Subfamília K de Receptores Semelhantes a Lectina de Células NK/metabolismo , Antígenos CD/química , Antígenos CD/metabolismoRESUMO
O completo entendimento dos fatores que determinam o sucesso ou a rejeição de um órgão transplantado (enxerto) requer o conhecimento de suas estruturas antigênicas, dos mecanismos de reconhecimento do antígeno, das diferentes populações celulares e da produção das citoninas pelo sistema imunológico do receptor, bem como dos eventos bioquímicos e moleculares que ocorrem no processo de rejeição dos transplantes. Neste capítulo será dado ênfase para os recentes progressos obtidos na compreensão das bases moleculares dos mecanismos de rejeição dos transplantes, pois esse conhecimento pode ser de fundamental importância para a elaboração de novos protocolos de imunossupressão e para o entendimento do mecanismo de ação de novas drogas imunossupressivas.
Assuntos
Humanos , Rejeição de Enxerto/imunologia , Antígenos HLA/química , Diferenciação Celular , Citocinas/química , Moléculas de Adesão Celular/química , Linfócitos T , Imunologia de TransplantesRESUMO
Os autores realizam uma revisäo sobre o papel de moléculas de adesäo sobre o desenvolvimento da resposta inflamatória, e mostram como a recente descriçäi dessas estruturas, expressas nas membranas dos leucócitos circulantes e da célula endotelial, têm esclarecido os processos de interaçäo leucócito-endotélio, fundamentais apra o recrutamento leucocitário. É discutido ainda, a açäo das principais drogas antiinflamatórias sobre a expressäo e funçäo dessas moléculas de adesäo e finalizando, é destacado o estudo de terapias anti-adesivas, como novas abordagens terapêuticas para o tratamento de doenças inflamatórias